Management of Locally Advanced Prostate Cancer

Jul 4, 2016 by in UROLOGY Comments Off on Management of Locally Advanced Prostate Cancer

© Springer-Verlag London 2015Vinod H. Nargund, Derek Raghavan and Howard M. Sandler (eds.)Urological Oncology10.1007/978-0-85729-482-1_47 47. Management of Locally Advanced Prostate Cancer Elaine T. Lam1   and L. Michael Glodé1 (1) Division of Medical Oncology, Department of Medicine, University of Colorado, Aurora,…

read more

Surgical Aspects of Prostate Cancer Management

Jul 4, 2016 by in UROLOGY Comments Off on Surgical Aspects of Prostate Cancer Management

1. Patients with previous abdominal/pelvic surgery 2. High body mass index 3. Previous prostatic surgery 4. Kidney transplantation/mesh abdominal repair The proponents of RPP describe it as procedure that provides…

read more

Expectant Management of Localized Prostate Cancer

Jul 4, 2016 by in UROLOGY Comments Off on Expectant Management of Localized Prostate Cancer

© Springer-Verlag London 2015Vinod H. Nargund, Derek Raghavan and Howard M. Sandler (eds.)Urological Oncology10.1007/978-0-85729-482-1_41 41. Expectant Management of Localized Prostate Cancer Maria Carmen Mir1 and Andrew J. Stephenson2   (1) Department of Urology, Cleveland Clinic, Cleveland, OH, USA (2) Glickman Urological…

read more

Principles of Radiotherapy in Urologic Tumors

Jul 4, 2016 by in UROLOGY Comments Off on Principles of Radiotherapy in Urologic Tumors

The BED normally carries a subscript corresponding to the assumed α/β since it is clearly different for large and small α/β. Thus, for any given fractionation schedule, one must determine…

read more

Genetics and Genito-Urinary Cancer

Jul 4, 2016 by in UROLOGY Comments Off on Genetics and Genito-Urinary Cancer

Fig. 3.1 Clonal evolution drives tumor progression. (a) Healthy epithelium. (b) The first oncogenic mutation occurs in a single epithelium cell (Yellow cell) resulting in the growth of a genetically…

read more

Surgical Management of Bladder Cancer

Jul 4, 2016 by in UROLOGY Comments Off on Surgical Management of Bladder Cancer

1. Muscle invasive (≥T2) bladder cancer 2. Select patients with recurrent high grade T1 or CIS 3. BCG and intravesical chemotherapy failures: high grade T1, with concomitant CIS, multifocal disease…

read more

Invasive Bladder Cancer: Combined Modality Treatment

Jul 4, 2016 by in UROLOGY Comments Off on Invasive Bladder Cancer: Combined Modality Treatment

Parameter Limitation Examples Laboratory methodology New assay system Standardization in progress What is “normal”? Optimal technology?  e.g. I-H vs. FISH?  e.g. RNA vs. protein?  Inter-laboratory variation Lab test applied to…

read more
Get Clinical Tree app for offline access